Drug · DIN 00022772
DILANTIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 7, 2023; first marketed December 31, 1951.
- Drug Identification Number (DIN)
- 00022772
- Company (DIN owner)
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Phenytoin N03AB02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PHENYTOIN SODIUM | 30 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 7, 2023: NOC 30937New Drug Submission (NDS) · Administrative: Change in Product Ownership
- May 13, 2020: NOC 23606New Drug Submission (NDS) · Change in product ownership
Other DINs named DILANTIN
- DIN 00022780 · Marketed